MUMBAI (Reuters) - The BSE Sensex rose on Thursday as Ranbaxy Laboratories surged 27.6 percent after higher U.S. quarterly sales eased some of the recent regulatory concerns about a key market for the drug maker, while a recovery in the rupee also supported the broader market.
Shares in Ranbaxy Laboratories provisionally rose 27.6 percent after the drugmaker posted better-than-expected April-June sales at its U.S. unit.
The Sensex provisionally closed 0.67 percent, while the Nifty ended 0.84 percent higher.
(Reporting by Himank Sharma; Editing by Rafael Nam)